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Abstract
Objective: To evaluate the influence of supportive treatment (SPT) during a mainte‐
nance period after implant placement on implant survival rate (SR) and incidence of 
peri‐implant diseases.
Material and methods: A systemic literature search for studies published up to 
June 2018 was conducted by two independent reviewers using Pubmed/MEDLINE, 
EMBASE, and Cochrane Central databases. Clinical controlled trials (CCT) involved 
in SPT protocol with more than 1‐year follow‐up were included. Quantitative meta‐
analyses were carried out to analyze the risk ratio (RR) of SR, the incidence of peri‐im‐
plantitis, and peri‐implant mucositis between SPT and non‐SPT groups. Any potential 
confounding factors were investigated using meta‐regression.
Results: Nine CCTs fulfilled the criteria. To evaluate the influence of SPT on SR, peri‐
implantitis, and peri‐implant mucositis, six of nine, three of nine, and three of nine 
articles were included in further meta‐analysis, respectively. SPT group significantly 
showed higher SR (RR: 1.10; p < 0.001), lower prevalence of peri‐implantitis (RR: 
0.25; p < 0.001) and peri‐implant mucositis (RR: 0.57; p < 0.001) than the non‐SPT 
group. Meta‐regression of the selected studies failed to find an association between 
SR, peri‐implantitis, and peri‐implant mucositis and confounding factors: application 
of chemical agents and the frequency of SPT.
Conclusion: SPT can potentially improve peri‐implant health in terms of SR, peri‐im‐
plantitis, and peri‐implant mucositis. Additionally, the correlation in recall interval and 
adjunctive use of chemical agents during SPT to peri‐implant diseases and implant 
loss could not be found.
K E Y W O R D S
maintenance, peri‐implantitis, supportive treatment, survival rate, systematic review and 
meta‐analysis
1  | INTRODUC TION
Peri‐implant diseases such as peri‐implantitis (PI) have recently 
gained much attention due to uprising prevalence. Recent consensus 
has concluded plaque as the main cause of peri‐implant mucositis 
and PI (Berglundh et al., 2018). Similar to the process from gingivitis 
to periodontitis, peri‐implant mucositis was regarded as the precur‐
sor for peri‐implantitis (Jepsen et al., 2015). It should be noted that 
in spite of the reversibility of peri‐implant mucositis, longer healing 
time compared to gingivitis was still required for complete disease 
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resolution (Salvi et al., 2012). Furthermore, controlling or treating 
peri‐implant lesions is regarded as unpredictable because of the sus‐
ceptibility in peri‐implant tissue by nature: parallel connective tissue 
fibers, stronger inflammatory response, and unencapsulated inflam‐
matory lesions (Tomasi et al., 2016).
It has been demonstrated that peri‐implant health can be main‐
tained through implant maintenance therapy (Salvi & Zitzmann, 
2014). Although there were many terms to describe implant mainte‐
nance such as supportive peri‐implant therapy (Monje et al., 2016), 
cumulative interceptive supportive therapy (CIST) (Lang, Wilson, & 
Corbet, 2000), they are almost identical to the traditional support‐
ive periodontal treatment (SPT), hence, the term SPT was adopted 
to describe the implant maintenance therapy in this study. In gen‐
eral, SPT includes clinical examination, radiographic evaluation, oral 
hygiene instructions, professional plaque control, and mechanical 
debridement with different devices (Frisch, Ziebolz, Vach, & Ratka‐
Krüger, 2014).
Several systematic reviews have tried to correlate the impor‐
tance of SPT with implant survival rates (SRs), the prevalence of 
peri‐implant diseases, implant bone loss, and other clinical pa‐
rameters (Hultin, Komiyama, & Klinge, 2007; Monje et al., 2016; 
Ramanauskaite & Tervonen, 2016; Salvi & Zitzmann, 2014). Aside 
from the participation of SPT, some other contributing factors could 
have influences on peri‐implant conditions in terms of patient‐ or 
prosthetic‐dependent indicators: smoking, biotype, and overdenture 
designs (Berglundh, Persson, & Klinge, 2002).
SPT plays a critical role in maintaining the stability of periodontal 
status from the perspective of bacteria amount, clinical outcomes, 
and further disease progression (Lang & Tonetti, 2003; Ramfjord, 
1993). Nevertheless, the concept of preventive maintenance should 
also be advocated in dental implants in terms of bacterial patterns 
(Agerbaek, Lang, & Persson, 2006; Ziebolz, Schmalz, Gollasch, 
Eickholz, & Rinke, 2017), cost‐effectiveness (Schwendicke, Tu, & 
Stolpe, 2015), biological complications (Berglundh et al., 2002; Salvi 
& Zitzmann, 2014), peri‐implant tissue and SR (Goh & Lim, 2017), 
and the long‐term stability of treated peri‐implantitis (Roccuzzo, 
Layton, Roccuzzo, & Heitz‐Mayfield, 2018).
Most of the previous reviews were focused only on the articles 
with SPT or did not conduct meta‐analyses, the present paper car‐
ried out a comprehensive systematic review, and meta‐analysis on 
papers that had both patients with and without SPT. That is to say, 
the primary purpose of this paper was to extract the data from arti‐
cles with both test and control groups for comparisons. In addition, 
the secondary purpose of the review was to find the correlation be‐
tween certain factors (the interval for maintenance, chemical agent 
application) and outcome of SPT.
2  | MATERIAL AND METHODS
This systematic review and meta‐analysis were reported in accord‐
ance with the 27‐item Preferred Reporting Items for Systematic 
Reviews and Meta‐Analyses (PRISMA) statement (Moher, Liberati, 
Tetzlaff, Altman, & PRISMA Group, 2009). Focused question was 
elaborated following the Population, Intervention, Comparison, and 
Outcome (PICO) criteria (Stone, 2002): “Do patients receiving SPT 
versus no SPT after implant placement have an improvement in im‐
plant SR and/or reduction in incidence of peri‐implant disease?”
P: Systemically healthy subjects who received one or more den‐
tal implants; I: After implant restoration, patients received SPT, in‐
cluding a full mouth examination, oral hygiene reinforcement, and 
professional prophylaxis; C: After implant restoration, patients did 
not receive SPT to serve as the comparison; O: The primary outcome 
of this review was SR of implants, the prevalence of peri‐implant mu‐
cositis and peri‐implantitis at patient level. Additionally, secondary 
outcomes considered the significance of other confounding factors 
for primary results (SPT interval and the use of chemical agents, such 
as antibiotics or antiseptic agents).
2.1 | Selection criteria
Eligible studies were included if they met the following inclusion 
criteria: (a) Any clinical studies, including prospective or retrospec‐
tive, randomized, or controlled clinical trials with SPT and non‐SPT 
groups; (b) Any SPT should be mentioned with details in articles for 
maintenance care; (c) At least 1‐year follow‐up period after implant 
prosthesis loading; (d) Data of peri‐implant conditions (either SR, 
bone level, plaque, and bleeding status, or prevalence of peri‐mu‐
cositis and/or peri‐implantitis) are required.
2.2 | Search strategy
The search strategy was mainly conducted by means of three elec‐
tronic databases—Pubmed/MEDLINE, EMBASE, and Cochrane 
Central for articles published up to June 2018. The search 
terms used in Pubmed/MEDLINE for collecting articles were: 
(((((((((((maintenance[MeSH Terms]) OR supportive treatment[Title/
Abstract]) OR supportive therapy[Title/Abstract]) OR supportive 
post‐implant treatment[Title/Abstract])) OR cumulative interceptive 
supportive therapy[Title/Abstract])) OR prevention[MeSH Terms])) 
OR oral hygiene[MeSH Terms])) AND ((((dental implant[MeSH 
Terms]) OR implant[Title/Abstract])) OR implantation[Title/
Abstract]). In EMBASE: ('maintenance therapy'/exp OR 'supportive 
therapy'/exp OR ('prevention'/exp AND 'control'/exp) OR 'mouth 
hygiene':ti,ab,kw) AND ('tooth implantation'/exp OR 'tooth implant'/
exp OR 'implant':ti,ab,kw). In Cochrane database, “supportive treat‐
ment” and “dental implant” were used as title/abstract.
In addition, a manual search of relevant articles from January 
2012 to June 2018 was conducted in the following journals: Journal 
of Dental Research, Clinical Oral Implants Research, Journal of Clinical 
Periodontology, Journal of Periodontology, Clinical Implant Dentistry and 
Related Research, European Journal of Oral Implantology, Journal of Oral 
and Maxillofacial Surgery, International Journal of Oral & Maxillofacial 
Implants, Implant Dentistry, International Journal of Periodontics and 
International of Periodontics and Restorative Dentistry, Journal of Oral 
Implantology. Additionally, previous systematic reviews assessing 
716  |     LIN et aL.
maintenance therapy for the prevention of peri‐implant diseases 
were also screened for article identification.
The articles derived from the search process were screened by 
two reviewers (CL and ZC) independently. Regarding selection cri‐
teria, titles and abstracts of search results were assessed, and then 
potential articles were evaluated in full‐text. κ value was calculated 
to assess the level of inter‐reviewer agreement concerning study in‐
clusion. Whenever there was a disagreement on selected studies, a 
decision was made after thorough discussion and consultation with 
a senior reviewer (HLW).
2.3 | Risk of bias assessment
The quality assessment of selected non‐randomized studies was evalu‐
ated for assessing the risk of bias with the Newcastle‐Ottawa Scale 
(NOS) (Stang 2010). The included clinical trials would be rated as 0–8 
stars from each parameter in Newcastle‐Ottawa scale (Wells et al., 2013).
2.4 | Data extraction and analyses
The data was extracted from the eligible articles by two independ‐
ent reviewers (CL and ZC). Any inter‐reviewer disagreement was re‐
solved by discussion and consulted with another reviewer (HLW). If 
there was any doubt or missing data, the corresponding authors of 
potential literatures were contacted for clarification.
All statistical analyses were conducted using one statistical software 
program (Stata software, v14.0; StataCorp). To standardize the reporting 
of our results, risk ratios (RRs) and 95% CI were calculated from the abso‐
lute number of events reported in each clinical trial; SRs, the prevalence 
of peri‐implant mucositis and peri‐implantitis were analyzed at the pa‐
tient level. Summary estimates of risk ratios (RR) were obtained with ran‐
dom‐effects‐models if heterogeneity across trials tested with the Q test 
(p < 0.10) and I2 statistics >75% proved to be high (Higgins & Thompson, 
2002). By definition, weighted by the inverse variance method, RR > 1 in‐
dicated a higher event rate of SPT group than the non‐SPT group. Meta‐
regression analysis was performed to analyze the potential influence of 
confounding factors, including SPT interval, and use of chemical agents.
F I G U R E  1   The screening process
TA B L E  1   Excluded articles with reasons
Author (year) Excluded articles with reasons
Henry et al. (1995) No exact numbers for post‐ implant 
outcomes
Hultin et al. (2000) No details for implant maintenance care
Leonhardt et al. (2002) No details for implant maintenance care
Telleman et al. (2006) No details for implant maintenance care
Pjetursson et al. (2012) No details for implant maintenance care
Mir‐Mari et al. (2012) No details for implant maintenance care
Frisch et al. (2014) No exact numbers for post‐implant 
outcomes
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The possibility of publication bias (Figure S1) was assessed with 
Harbord plot for dichotomous data, considering a significant publi‐
cation bias if p < 0.05 (Harbord, Egger, & Sterne, 2006).
3  | RESULTS
3.1 | Study selection
The whole literature screening process was presented in Figure 1. 
Initial screening yielded a total of 795 records from electronic search 
(Pubmed: 487; EMBASE: 254; Cochrane: 54), and 22 records were 
found by hand‐searching. After duplicates discarded, titles and ab‐
stracts revision, 16 articles were selected for full‐text screening, and 
seven of them were further excluded with reasons (Table 1; Frisch et 
al., 2014; Henry, Bower, & Wall, 1995; Hultin, Gustafsson, & Klinge, 
2000; Leonhardt, Gröndahl, Bergström, & Lekholm, 2002; Mir‐Mari, 
Mir‐Orfila, Figueiredo, Valmaseda‐Castellón, & Gay‐Escoda, 2012; 
Pjetursson et al., 2012; Telleman, Meijer, & Raghoebar, 2006). Finally, 
nine eligible articles (Aguirre‐Zorzano, Vallejo‐Aisa, & Estefanía‐
Fresco, 2013; Anner, Grossmann, Anner, & Levin, 2010; Costa et 
al., 2012; Gay et al., 2016; Hoerler et al., 2017; Rinke, Ohl, Ziebolz, 
Lange, & Eickholz, 2011; Roccuzzo, Bonino, Aglietta, & Dalmasso, 
2012; Roccuzzo, Bonino, Dalmasso, & Aglietta, 2014; Roccuzzo, De 
Angelis, Bonino, & Aglietta, 2010) were included in the systematic 
review. Except for one study (Roccuzzo et al., 2012) without avail‐
able data, the remaining eight articles were included in the quan‐
titative synthesis. To evaluate the influence of SPT on SR, PI and 
MU, six (Aguirre‐Zorzano et al., 2013; Anner et al., 2010; Gay et al., 
2016; Roccuzzo et al., 2010, 2014) of nine, three (Aguirre‐Zorzano 
et al., 2013; Costa et al., 2012; Rinke et al., 2011) of nine, and three 
(Aguirre‐Zorzano et al., 2013; Costa et al., 2012; Rinke et al., 2011) 
of nine articles were included in further meta‐analysis respectively. 
The k value for inter‐reviewer agreement for title/abstract and full‐
text screen was 0.87 and 0.91, respectively.
3.2 | Description of studies
Main features of included studies were summarized with details, 
and articles with clinical variables were shown in terms of the dif‐
ferences in SPT and non‐SPT (Table 2). First of all, five of the related 
articles were retrospective studies (Anner et al., 2010; Costa et al., 
2012; Gay et al., 2016; Hoerler et al., 2017; Rinke et al., 2011) and 
four of them were prospective studies (Aguirre‐Zorzano et al., 2013; 
Roccuzzo et al., 2010, 2012, 2014). Besides, some of the studies tried 
to add other confounding factors in comparison with SPT. For exam‐
ple, two articles from the same research group addressed attentions 
on different types of implant surfaces and even the severity of peri‐
odontitis of patients in three different groups (Roccuzzo et al., 2012, 
2014). As for the content of maintenance care programs for dental 
implants, most of the studies focused on oral hygiene reinforcement 
and mechanical debridement with specific tools, including titanium, 
carbon fiber or even steel curettes, scalers, ultrasonic devices with 
plastic tips, and rubber cup with paste. No matter which term they 
used for SPT, coronal prophylaxis, and mechanical debridement were 
the main methods for implant maintenance. Only one study not only 
used above method but also air‐polish kit and dental floss for their 
maintenance protocol (Gay et al., 2016). However, the necessity of 
using chemical agents for supportive treatment is controversial, with 
three out of nine studies utilizing antibiotics, antiseptic agents or 
fluoride gel during the maintenance phase (Frisch, Ziebolz, Vach, & 
Ratka‐Krüger, 2015; Rinke et al., 2011; Roccuzzo et al., 2010, 2012, 
2014). The mean duration of follow‐up ranged from 1 to 16 years. 
Furthermore, the interval of recall visits varied based on authors' 
preference such as every 3 or 6 months or even tailored to each 
individual (Roccuzzo et al., 2010, 2012, 2014). Nonetheless, the SPT 
carried out in all selected papers should include full mouth examina‐
tion and professional prophylaxis at least annually.
3.3 | Risk of bias and quality assessment
Among all included articles, there were nine clinical controlled trials 
(CCTs) fulfilled the inclusion criteria. The risk of bias in nine included 
CCTs were assessed and summarized (Table S1), four of nine articles 
were prospective studies (Aguirre‐Zorzano et al., 2013; Roccuzzo 
et al., 2010, 2012, 2014). In summary, the assessment of all CCTs 
comprised two studies with less than six stars (Hoerler et al., 2017; 
Roccuzzo et al., 2012), two studies with seven stars (Gay et al., 
2016; Roccuzzo et al., 2012, 2014) and five studies with eight stars 
(Aguirre‐Zorzano et al., 2013; Anner et al., 2010; Costa et al., 2012; 
Rinke et al., 2011; Roccuzzo et al., 2010) according to all parameters 
in the criteria.
3.4 | Primary outcomes (SPT and non‐SPT)
Regarding the primary outcomes of SPT, the present review mainly 
emphasized either SR of dental implants or the percentage of peri‐
implant disease in both groups. Based on six included CCTs (Aguirre‐
Zorzano et al., 2013; Anner et al., 2010; Gay et al., 2016; Hoerler 
et al. 2017; Roccuzzo et al., 2010, 2012) in meta‐analysis, SPT 
groups revealed significantly higher SR (RR: 1.10; 95% CI: 1.07–1.14; 
p < 0.001) at patient level (Figure 2), with a moderate heterogene‐
ity (I2 = 31.9%, p = 0.163). In two studies from the same group, all 
patients were divided into three groups based on different severity 
of chronic periodontitis, and the results showed stronger impacts 
on SR particularly in titanium plasma‐spray (TPS) surfaced implants 
and patients with chronic periodontitis (Roccuzzo et al., 2012, 
2014). Except for one study with 1‐year follow‐up time (Gay et al., 
2016), the data were extracted from the studies with comparably 
long observation periods, to be more specific, from 30.5 months to 
10 years. Additionally, meta‐analysis was conducted in three stud‐
ies (Aguirre‐Zorzano et al., 2013; Costa et al., 2012; Rinke et al., 
2011) for peri‐implant disease assessment at patient level, and the 
results showed lower prevalence of peri‐implant mucositis (RR: 0.57; 
95% CI: 0.43–0.76; p < 0.001) and peri‐implantitis (RR: 0.25; 95% 
CI: 0.13–0.48; p < 0.001) in SPT groups with statistical significance 
(Figures 3 and 4). Among the three studies, the follow‐up periods for 
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observation ranged from 68.5 months to 5 years. The heterogene‐
ity between studies was high for the prevalence of peri‐mucositis 
(I2 = 76.7%, p = 0.014), and moderate for the prevalence of peri‐im‐
plantitis (I2 = 46.2%, p = 0.156).
3.5 | Secondary outcomes (correlating factors)
The confounding factors, including SPT interval, and use of chemi‐
cal agent during SPT were analyzed by meta‐regression. In SR, the p 
value of the meta‐regression for the SPT interval was 0.324, for the 
use of chemical agent was 0.246, indicating the above factors did 
not significantly influence the outcome of analysis. Also, no signifi‐
cant influence was found among these factors for the prevalence of 
peri‐mucositis (p = 0.324 and 0.462, respectively) and peri‐implanti‐
tis (p = 0.780 and 0.818, respectively).
3.6 | Other clinical parameters
Aside from the SR and peri‐implant disease around implants, sev‐
eral studies provided other clinical parameters for comparison, 
TA B L E  2   Included articles with supportive treatment (SPT) and without supportive treatment (non‐SPT) groups
Author (year)
Study type 
(R or P)
Chemical (F, 
AS, AB or N)
Mechanical 
(OHI, Int, S) Interval
Average FU 
duration
(M or Y)
Loss FU at 
the end
Test
SPT
(Pt N)
Survival
N (%)
PIMS
N (%)
PIS
N (%)
Others
BL: N (%), BoP, PI, 
FMPS, FMBS: %
Control
Non‐SPT
(Pt N)
Survival
N (%)
PIMS
N (%)
PIS
N (%)
Others
BL: N (%),
BoP, PI, FMPS, FMBS: 
%
Anner et al. 
(2010)
R NR NR Annual 30.8M NR P: 246
I: 873
P: 225 (91.5)
I: 845 (96.8)
NR NR NR P: 229
I: 753
P: 192 (83.8)
I: 704 (93.5)
NR NR NR
Roccuzzo et al. 
(2010) (HP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
P: 24 P: 22 (91.7) NR NR BL > 3 mm:
2 (8.3)
P: 4 P: 4 (100) NR NR BL > 3 mm:
0 (0)
Roccuzzo et al. 
(2010)(ModP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 26 P: 25 (96.2) NR NR BL > 3 mm:
3 (11.5)
P: 11 P: 6 (54.5) NR NR BL > 3 mm:
7 (63.6)
Roccuzzo et al. 
(2010) (SevP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 29 P: 26 (89.7) NR NR BL > 3 mm:
7 (24.1)
P: 7 P: 3 (42.9) NR NR BL > 3 mm:
4 (57.1)
Rinke et al. 
(2011)
R F OHI, Int 3–6 M 68.2M NR P: 58 NR P: 17 (29.3) P: 1 (1.7) NR P: 31 NR P: 23 (74.2) P: 9 (29.3) NR
Costa et al. 
(2012)
R NR OHI, Int, Annual 5Y NR P: 39 NR P: 20 (51.5) P: 7 (18) BoP:
41.7→33.3
P: 41 NR P: 23 (56.1) P: 18 (43.9) BoP:
50.2→62.7
Roccuzzo et al. 
(2012) (HP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
24 NR NR NR PI: 17.2 4 NR NR NR PI: 11.4
Roccuzzo et al. 
(2012) (ModP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
26 NR NR NR PI: 25 11 NR NR NR PI: 38.5
Roccuzzo et al. 
(2012) (SevP)
Pr AS, AB OHI, Int, S Tailored 10Y 29 NR NR NR PI: 20.3 7 NR NR NR PI: 39.6
Aguirre‐
Zorzano et al. 
(2013) (HP)
Pr NR OHI, Int
Occlusion check
4M 4Y NR P: 27
I: 123
P: 27 (100)
I: 123 (100)
P: 5 (18.5) P : 1 (3.7) PI: 20.34 P: 22
I: 123
P: 21 (95.5)
I: 122 (99.2)
P: 11 (50) P: 5 (22.7) PI: 59.63
Roccuzzo et al. 
(2014) (HP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
P: 19
I: 32
P: 19 (100) NR NR FMPS:
27.6→19
FMBS: 23.4→15.8
P: 13
I: 54
P: 13 (100) NR NR FMPS:
31.1→26.5
FMBS: 27.5→22.2
Roccuzzo et al. 
(2014) (ModP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 25
I: 52
P: 25 (100) NR NR FMPS:
34→23.4
FMBS: 30.4→20.1
P: 21
I: 96
P: 19 (93.2) NR NR FMPS:
42.6→32.7
FMBS: 44.5→31.2
Roccuzzo et al. 
(2014) (SevP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
P: 31
I: 72
P: 30 (98.6) NR NR FMPS:
47.4→22.9
FMBS: 45.6→20.3
P: 14
I: 102
P: 13 (93.3) NR NR FMPS:
60.7→46.9
FMBS: 56.2→43.2
Gay et al. 
(2016)
R NR OHI, Int Annual 1Y NR P: 247 P: 241 (97.6) NR NR NR P: 627 P: 79 (87.4) NR NR NR
Hoerler et al. 
(2017) 
(All edentulous 
arch)
R NR Int <6M 20Y Test: P: 6
Control: P: 8
P: 49
I: 332
P: 43 (87.8) NR NR SR free of soft tissue 
pathology: 14 (75)
P: 100
I: 609
P: 91 (91) NR NR SR free of soft tissue 
pathology: 18 (87)
Abbreviations: AB, antibiotics; AS, antiseptic agents; BL, bone loss; BoP, bleeding on probing; F, fluoride gel; FMBS, full mouth bleeding score;  
FMPS, full mouth plaque score; FU, follow‐up; I, implant; Int, instrumentation; M, months; N, numbers; N, none; NR, no records; P, patient;  
PI, plaque index; PIMS, peri‐implant mucositis; PIS, peri‐implantitis; Pr, prospective; R, retrospective; S, surgery; SR, survival rate.
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including peri‐implant marginal bone loss, pocket depth, attach‐
ment loss, bleeding on probing, plaque index, plaque score, full 
mouth bleeding index, and plaque index (Table 2). Because of the 
difference in units and definition for each data, it was not possible 
to conduct a meta‐analysis in present review. Nevertheless, in five 
CCTs (Aguirre‐Zorzano et al., 2013; Costa et al., 2012; Roccuzzo 
et al., 2010, 2012, 2014), statistically higher incidence of bone 
loss, bleeding tendency and plaque accumulation could be found 
in non‐SPT groups.
4  | DISCUSSION
Our study found that different SPT treatment protocols were used 
across studies and it was impossible to identify a standard SPT 
protocol with specific instruments. In spite of the various terms of 
implant maintenance after placement, every program shared the 
similarity in part of components, including a review of dental and 
medical history, full mouth examination, improvement of oral hy‐
giene and plaque removal procedure (Armitage & Xenoudi, 2016). 
TA B L E  2   Included articles with supportive treatment (SPT) and without supportive treatment (non‐SPT) groups
Author (year)
Study type 
(R or P)
Chemical (F, 
AS, AB or N)
Mechanical 
(OHI, Int, S) Interval
Average FU 
duration
(M or Y)
Loss FU at 
the end
Test
SPT
(Pt N)
Survival
N (%)
PIMS
N (%)
PIS
N (%)
Others
BL: N (%), BoP, PI, 
FMPS, FMBS: %
Control
Non‐SPT
(Pt N)
Survival
N (%)
PIMS
N (%)
PIS
N (%)
Others
BL: N (%),
BoP, PI, FMPS, FMBS: 
%
Anner et al. 
(2010)
R NR NR Annual 30.8M NR P: 246
I: 873
P: 225 (91.5)
I: 845 (96.8)
NR NR NR P: 229
I: 753
P: 192 (83.8)
I: 704 (93.5)
NR NR NR
Roccuzzo et al. 
(2010) (HP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
P: 24 P: 22 (91.7) NR NR BL > 3 mm:
2 (8.3)
P: 4 P: 4 (100) NR NR BL > 3 mm:
0 (0)
Roccuzzo et al. 
(2010)(ModP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 26 P: 25 (96.2) NR NR BL > 3 mm:
3 (11.5)
P: 11 P: 6 (54.5) NR NR BL > 3 mm:
7 (63.6)
Roccuzzo et al. 
(2010) (SevP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 29 P: 26 (89.7) NR NR BL > 3 mm:
7 (24.1)
P: 7 P: 3 (42.9) NR NR BL > 3 mm:
4 (57.1)
Rinke et al. 
(2011)
R F OHI, Int 3–6 M 68.2M NR P: 58 NR P: 17 (29.3) P: 1 (1.7) NR P: 31 NR P: 23 (74.2) P: 9 (29.3) NR
Costa et al. 
(2012)
R NR OHI, Int, Annual 5Y NR P: 39 NR P: 20 (51.5) P: 7 (18) BoP:
41.7→33.3
P: 41 NR P: 23 (56.1) P: 18 (43.9) BoP:
50.2→62.7
Roccuzzo et al. 
(2012) (HP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
24 NR NR NR PI: 17.2 4 NR NR NR PI: 11.4
Roccuzzo et al. 
(2012) (ModP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
26 NR NR NR PI: 25 11 NR NR NR PI: 38.5
Roccuzzo et al. 
(2012) (SevP)
Pr AS, AB OHI, Int, S Tailored 10Y 29 NR NR NR PI: 20.3 7 NR NR NR PI: 39.6
Aguirre‐
Zorzano et al. 
(2013) (HP)
Pr NR OHI, Int
Occlusion check
4M 4Y NR P: 27
I: 123
P: 27 (100)
I: 123 (100)
P: 5 (18.5) P : 1 (3.7) PI: 20.34 P: 22
I: 123
P: 21 (95.5)
I: 122 (99.2)
P: 11 (50) P: 5 (22.7) PI: 59.63
Roccuzzo et al. 
(2014) (HP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
P: 19
I: 32
P: 19 (100) NR NR FMPS:
27.6→19
FMBS: 23.4→15.8
P: 13
I: 54
P: 13 (100) NR NR FMPS:
31.1→26.5
FMBS: 27.5→22.2
Roccuzzo et al. 
(2014) (ModP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 25
I: 52
P: 25 (100) NR NR FMPS:
34→23.4
FMBS: 30.4→20.1
P: 21
I: 96
P: 19 (93.2) NR NR FMPS:
42.6→32.7
FMBS: 44.5→31.2
Roccuzzo et al. 
(2014) (SevP)
Pr AS, AB OHI, Int, S Tailored 10Y P: 11
I: 18
P: 31
I: 72
P: 30 (98.6) NR NR FMPS:
47.4→22.9
FMBS: 45.6→20.3
P: 14
I: 102
P: 13 (93.3) NR NR FMPS:
60.7→46.9
FMBS: 56.2→43.2
Gay et al. 
(2016)
R NR OHI, Int Annual 1Y NR P: 247 P: 241 (97.6) NR NR NR P: 627 P: 79 (87.4) NR NR NR
Hoerler et al. 
(2017) 
(All edentulous 
arch)
R NR Int <6M 20Y Test: P: 6
Control: P: 8
P: 49
I: 332
P: 43 (87.8) NR NR SR free of soft tissue 
pathology: 14 (75)
P: 100
I: 609
P: 91 (91) NR NR SR free of soft tissue 
pathology: 18 (87)
Abbreviations: AB, antibiotics; AS, antiseptic agents; BL, bone loss; BoP, bleeding on probing; F, fluoride gel; FMBS, full mouth bleeding score;  
FMPS, full mouth plaque score; FU, follow‐up; I, implant; Int, instrumentation; M, months; N, numbers; N, none; NR, no records; P, patient;  
PI, plaque index; PIMS, peri‐implant mucositis; PIS, peri‐implantitis; Pr, prospective; R, retrospective; S, surgery; SR, survival rate.
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Unlike the previous reviews, the present review divided the implant 
care into mechanical and chemical parts, and it showed large similar‐
ity in mechanical care even with different devices. Also, the present 
study was a pioneer in making a comparison between SPT and non‐
SPT groups based on the outcomes in meta‐analysis.
4.1 | Primary outcomes
It has been shown that plaque control has been considered as one 
of the main triggers for peri‐implant disease and even implant loss 
(Schou, Holmstrup, Hjørting‐Hansen, & Lang, 1992). SPT has been 
regarded as the first protective barrier to prevent from peri‐implant 
disease progression (Hultin et al., 2007; Monje et al., 2016). A re‐
cent review further supports the importance of SPT after treatment 
of peri‐implantitis (Roccuzzo et al., 2018). In accordance with the 
findings, the statistical analysis in present review revealed that SPT 
patients obtained higher SR and lower prevalence of peri‐implant mu‐
cositis and peri‐implantitis during long‐term follow‐up. Despite the 
uncertain causal relationship, SPT could be beneficial in enhancing 
peri‐implant conditions in perspectives of better oral hygiene, plaque 
reduction and early detection of disease in initial stages.
According to the observation in the meta‐analysis (Figure 2), the 
results possibly implied that SPT could play a more important role 
in certain circumstances: Titanium plasma surfaced implants in pa‐
tients with a history of chronic periodontitis. To date, the history of 
periodontitis has been considered as one the most well‐known risk 
indicators (Heitz‐Mayfield, 2008). Even more, patients with gener‐
alized aggressive periodontitis were regarded as more susceptible 
to peri‐implant diseases (Swierkot, Lottholz, Flores‐de‐Jacoby, & 
Mengel, 2012), and one cohort study showed more bone and at‐
tachment loss at implants even under periodic recall schedule for 
10 years (Mengel, Behle, & Flores‐de‐Jacoby, 2007). Even though 
most articles still believed in the strong correlation between history 
of periodontitis and the development of peri‐implantitis (Ferreira, 
Silva, Cortelli, Costa, & Costa, 2006; Monje et al., 2016), one retro‐
spective study proposed that residual pockets rather than history 
of periodontitis could be the key factor of increased risk of peri‐im‐
plantitis (Lee, Mattheos, Nixon, & Ivanovski, 2012). Likewise, even 
for treated implants, the importance of controlling residual pocket 
by means of SPT also was highlighted in a 5‐year follow‐up study 
(Serino, Turri, & Lang, 2015). In the present study, no statistical evi‐
dence could be addressed from the history of periodontitis with the 
participation in SPT. However, according to previous studies, resid‐
ual pockets and non‐SPT might be the more crucial factors to lower 
the SR of implants, and the statistical proof should be required by 
means of thorough investigation in related studies.
4.2 | Secondary outcomes
Currently, there is no consensus on specific recall frequency for 
every patient, and an optimal recall interval may not be suitable for 
all cases. For natural dentition, a 5‐year observation study showed 
F I G U R E  2   Meta‐analysis was conducted in assessing survival rate (SR) between supportive post‐implant treatment (SPT) and non‐SPT 
groups. TPS: titanium plasma‐spray implant; SLA: sandblasted and acid‐etched implants
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shorter recall intervals could be more favorable in plaque reduction 
and help reduce bleeding tendency but not be additionally beneficial 
to other clinical parameters (Rosén et al., 1999). Furthermore, one 
systemic review failed to prove the necessity of fixed recall inter‐
val regimens within 3–6 months (Farooqi, Wehler, Gibson, Jurasic, 
& Jones, 2015). In harmony with the findings, one study obtained 
the results that frequency of visits could not have impacts on peri‐
implant health (Ferreira et al., 2006). Based on Lang's CIST program 
for implant care, all treatment protocols must depend on the need 
and diagnosis of peri‐implant tissue; however, specific interval time 
was not mentioned as a reference (Lang et al., 2000). On the con‐
trary, a minimal recall interval of 5–6 months was suggested (Monje 
et al., 2016). In the present review, a specific time point for recall 
interval could not be obtained after statistical investigation, and the 
outcome could attribute to different and uncontrolled susceptibility 
to peri‐implant diseases.
Considering the heterogeneity in maintenance strategies, 
plaque removal can be simply divided into chemical and mechan‐
ical approaches. The need of using chemical agents remains con‐
troversial. In Lang's CIST regimen, either chlorhexidine alone or 
F I G U R E  4   Meta‐analysis was performed to examine the prevalence of peri‐implantitis in SPT and non‐SPT groups
F I G U R E  3   Meta‐analysis was performed to examine the prevalence of peri‐implant mucositis in SPT and non‐SPT groups
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combined with antibiotics could be considered in situations of 
suppuration with bleeding and pocket depth of more than 5 mm 
(Lang et al., 2000). Conversely, one randomized clinical trial 
showed the supplemental application of chlorhexidine vanish had 
no significant additional benefits comparing to other mechanical 
methods alone (Ziebolz, Klipp, et al., 2017). Based on one review 
with meta‐analysis, adjunctive therapy with chemical agents could 
not improve the clinical outcomes achieved by mechanical de‐
bridement (Schwarz, Schmucker, & Becker, 2015). Tracing back to 
present review, no better outcomes could be obtained with addi‐
tional chemical agents, which implies that antibiotics or antiseptic 
agents' application during SPT may not be needed. In summary, 
data from this study implies that any form of SPT is better than 
nothing in terms of increasing implant survival and preventing 
peri‐implantitis incidence.
4.3 | Limitations
The limitations of this review should be highlighted as below. First, 
all included articles in present review were not RCT but CCTs or 
even cohort studies, which could inevitably weaken the quality of 
studies. For this reason, only limited articles could be included for 
meta‐analysis. Nevertheless, out of respect of ethical issues, it was 
not possible to set up a well‐designed RCT with patients intention‐
ally exclude from SPT program as the control group. Second, the 
complete data for primary outcomes could merely be extracted at 
the patient level, and some deviation could also be found from pa‐
tient‐ or implant‐based records. To eliminate the bias, the number 
of included articles in the meta‐analysis would be consequently 
reduced. Apart from the heterogeneity in primary outcomes, par‐
ticularly with vague descriptions of the content of SPT and the 
diverse follow‐up period, there was no consistent way to repre‐
sent bone loss, plaque accumulation, and bleeding tendency units. 
Hence, the meta‐analysis in the present review could not be con‐
ducted in clinical parameters. In addition, multiple factors could be 
responsible for the peri‐implant disease, and none of the include 
articles could comprehensively be ruled out all possible factors for 
each patient, such as implant surface, implant locations, implant‐
supported prosthesis design, smoking habits and patient‐based 
potential systematic disease. Last but not least, the present review 
includes only English language publications, which may count for 
selection bias. Additionally, the protocol has not been registered 
in the clinical trial web portal. With the limitation of this review, all 
results should be interpreted with caution.
4.4 | Summary from the review
Despite the limitations mentioned in the review, the results still re‐
veal insight into the clinical implications after implant placement.
1. Provision of maintenance care is better than not providing main‐
tenance care. The results indicated positive impacts of SPT 
for implant maintenance compared to non‐SPT groups.
2. A minimum common protocol of SPT should include full mouth ex‐
amination and professional prophylaxis (oral hygiene instructions, 
plaque control and mechanical instrumentation) at least annually.
3. The evidence of other factors about SPT, such as chemical agent 
application and recall intervals, was inconclusive.
5  | CONCLUSION
With the limitations of this review, SPT can potentially improve peri‐
implant health in terms of implant SR, prevent peri‐implant mucosi‐
tis, and peri‐implantitis. Additionally, the correlation in recall interval 
and adjunctive use of chemical agents during SPT to implant SR and 
incidence of peri‐implant mucositis and peri‐implantitis could not 
be found in the present review. In the future, more well‐controlled 
studies with consistent and complete data are required for investi‐
gating the efficacy of SPT.
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